Did You Know...
...that the x-ray was discovered purely by accident? When German physicist Wilhelm Konrad von Roentgen was experimenting with cathode rays in 1895, he put an activated Crookes tube in a book and went out to lunch. When he returned, he discovered that a key that had also been placed in the book showed up as an image on the developed film!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110212974 | METHOD FOR IDENTIFYING COMPOUNDS USEFUL FOR TREATING AND/OR PREVENTING DISEASE-ASSOCIATED BONE LOSS The present invention concerns a method for identifying a compound which inhibits the activation of RAC GTPase by DOCK5 protein comprising the steps of (i) coexpressing the DOCK5 and the RAC proteins in a cell, wherein said DOCK5 protein induces the conversion of inacti... | 09/01/2011 |
| 20100080843 | Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis The present invention relates to inhibiting angiogenesis with sulfur- or selenium-containing compounds, and polymeric forms thereof, in mammals including animals and humans. Sulfur- or selenium-containing compounds, and polymeric forms thereof, can be used alone or in c... | 04/01/2010 |
| 20100063136 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES N-Substituted sulfoximines are effective at controlling insects.... | 03/11/2010 |
| 20100056579 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES N-Substituted sulfoximines are effective at controlling insects.... | 03/04/2010 |
| 20070293486 | Alpha-Keto Carbonyl Calpain Inhibitors The present invention relates to novel α-keto carbonyl calpain inhibitors for the treatment of neurodegenerative diseases and neuromuscular diseases including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and other muscular dystrophies. Disuse atrophy and gene... | 12/20/2007 |
| 20070265316 | Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof The invention provides compositions, pharmaceutical preparations and methods for activation of the ΔF508 cystic fibrosis transmembrane conductance regulator protein (ΔF508 CFTR) that are useful for the treatment and study of cystic fibrosis (CF). The compositions and ... | 11/15/2007 |
| 20070259929 | Therapeutic Compounds Therapeutic substituted cyclopentane compounds, and compositions, medicaments, and therapeutic methods related thereto are disclosed herein.... | 11/08/2007 |
| 20070142456 | Method for inhibiting cancer development by fatty acid synthase inhibitors A method for inhibiting or preventing cancer development by the administration of fatty acid synthase (FAS) inhibitors. In particular, the present invention prohibits or delays the development of invasive cancer from pre-malignant (non-invasive) lesions that express FAS... | 06/21/2007 |
| 20070110680 | Methods and compositions for controlling biofilm development A method of cleaning or protecting surfaces by treatment with compositions comprising N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL) blocking compounds and/or N-butyryl-L-homoserine lactone (BHL) analogs, either in combination or separately. ... | 05/17/2007 |
| 20070105860 | Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors. ... | 05/10/2007 |
| 20070037870 | Novel substance having alpha-glucosidase inhibiting activity and food containing the same To provide a novel substance having α-glucosidase inhibiting activity, derived from natural products and being safe, which substance has not only a blood sugar ameliorating activity being effective in the prevention or treatment of diabetes or obesity but also an acti... | 02/15/2007 |
| 20060247222 | Glycosidase inhibitors and methods of synthesizing same Methods for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycosidase inhibitors are described. In some embodiments the compounds of the invention may have the general formula (I) or (II): Th... | 11/02/2006 |
| 20060235057 | Phenyl compounds Compounds of formula (I) or derivatives thereof: wherein A, B, Z, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutica... | 10/19/2006 |
| 20060235003 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives The present invention relates to compounds of formula I wherein the substituents are as defined below. The compounds of formula are useful for the treatment of diseases such as schizophrenia, including both the positive and the negative symptoms of schizophrenia and ot... | 10/19/2006 |
| 20060217381 | Methods and compostions for specific inhibition of protein splicing by small molecules The present invention relates to compositions (i.e., various organic small molecules as exemplified herein) and methods for the inhibition of protein splicing and especially relates to the inhibition of protein autosplicing of intein-containing proteins. Additionally, t... | 09/28/2006 |
| 20060178425 | FUNGICIDAL CARBOXAMIDES Compounds of Formula I are disclosed which are useful as fungicides wherein X is —O—, —CH(R11)— or ═C(R11)—; R1 is H or C1-C2 al... | 08/10/2006 |
| 20060014803 | Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics The invention concerns novel diarylselenide compounds corresponding to formula (I): and the use thereof in pharmaceutical compositions in human or veterinary medicine (in the treatment of dermatological, rheumatic, cardiovascular and ophthalmologic pathologies in pa... | 01/19/2006 |
| 20050227959 | Heterocyclic compound having oxime group The present invention provides a compound that has an excellent inhibitory activity on STAT6 activation and is effective against allergic diseases, and a medicinal composition thereof. According to the present invention, disclosed is the compound represented by the Gen... | 10/13/2005 |
| 20050159449 | Cannabinoids Compounds of the formula: wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are u... | 07/21/2005 |
| 20050004203 | Thiolactones This invention provides new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, inhibiting angiogenesis... | 01/06/2005 |
